We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WRLD icon
1201
World Acceptance Corp
WRLD
$950M
– –
-86
Closed -$10.6K
WSBC icon
1202
WesBanco
WSBC
$3.95B
– –
-4,140
Closed -$116K
WST icon
1203
West Pharmaceutical
WST
$23.1B
– –
-544
Closed -$179K
WTBA icon
1204
West Bancorporation
WTBA
$464M
– –
-2,984
Closed -$53.4K
WTM icon
1205
White Mountains Insurance
WTM
$5.47B
– –
-5
Closed -$9.09K
WULF icon
1206
TeraWulf
WULF
$9.15B
– –
-3,538
Closed -$15.7K
WYNN icon
1207
Wynn Resorts
WYNN
$10.1B
– –
-1,269
Closed -$114K
WY icon
1208
Weyerhaeuser
WY
$17.3B
– –
-6,437
Closed -$183K
XENE icon
1209
Xenon Pharmaceuticals
XENE
$6.32B
– –
-26
Closed -$1.01K
XHR
1210
Xenia Hotels & Resorts
XHR
$1.98B
– –
-9,476
Closed -$136K
XNCR icon
1211
Xencor
XNCR
$1.44B
– –
-6,749
Closed -$128K
XP icon
1212
XP
XP
$8.62B
– –
-1,068
Closed -$18.8K
XPO icon
1213
XPO
XPO
$25B
– –
-625
Closed -$66.3K
YOU icon
1214
Clear Secure
YOU
$5.26B
– –
-8,423
Closed -$158K
ZEUS
1215
DELISTED
Olympic Steel
ZEUS
– –
-2,184
Closed -$97.9K
ZETA icon
1216
Zeta Global
ZETA
$4.77B
– –
-6,647
Closed -$117K
ZIMV
1217
DELISTED
ZimVie
ZIMV
– –
-3,616
Closed -$66K
ASTH icon
1218
Astrana Health
ASTH
$2B
– –
-388
Closed -$15.7K
TEN
1219
Tsakos Energy Navigation Ltd
TEN
$1.19B
– –
-4,014
Closed -$118K
PENG
1220
Penguin Solutions Inc
PENG
$2.76B
– –
-5,307
Closed -$121K
AAMI
1221
Acadian Asset Management
AAMI
$2.88B
– –
-2,837
Closed -$62.9K
XYZ
1222
Block Inc
XYZ
$45.9B
– –
-1,682
Closed -$108K
EQC
1223
DELISTED
Equity Commonwealth
EQC
– –
-358
Closed -$6.95K
PYCR
1224
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
– –
-4,879
Closed -$62K
NVRO
1225
DELISTED
NEVRO CORP.
NVRO
– –
-8,876
Closed -$74.7K
46 47 48
49
50

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.